ClinicalTrials.Veeva

Menu

The Acute Effects of Food Structure on Post Prandial Glucose and Subsequent Metabolic Responses

Imperial College London logo

Imperial College London

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: chickpea

Study type

Interventional

Funder types

Other

Identifiers

NCT03424187
15HH3069

Details and patient eligibility

About

Aims: To investigate the effects of different food structures on glucose concentrations and subsequent metabolic responses including insulin,GIP, GLP-1 DESIGN: A randomised, controlled, clinical trial.

Full description

Rationale:

There is very little evidence at the present time in the role of food structure in glucose homeostasis. There is circumstantial evidence that foods consumed intact have great effects on suppressing appetite.

To test the effect of three structurally different meals with the same nutritional content and volume on appetite regulation. Each participant will receive the following meals:

Solid meal group. Milled (intact-cell) meal group. Milled (destroyed-cell) meal group.

All of which will contain the same macro and micro nutrients from the same food sources

Enrollment

15 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Gender: male and female
  • Age ≥ 18 years ≤ 65 years
  • Normal weight as classified by BMI 20-29.9 kg/m2
  • Healthy, not diagnosed with any chronic diseases assessed as appropriate for inclusion, based on the pre-study screening.
  • Willingness and ability to understand, participate and to comply with the study requirements
  • Willingness and ability to give written informed consent

Exclusion criteria

  • Has thyroid defects
  • Under hormone or steroids therapy
  • Is pregnant or lactating (female)
  • Had given birth within the past year (female)
  • Is taking drugs that could affect appetite or plasma glucose levels.
  • Is taking natural remedies that modulate appetite or plasma glucose levels.
  • Has excessive alcohol intake
  • Had blood donation within 12wks prior to start date
  • Psychiatric illness
  • Smokers
  • History of any disease with unknown outcome
  • Has diabetes
  • Has nut allergy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15 participants in 3 patient groups

whole chickpea
Experimental group
Description:
a test meal containing 26g available carbohydrates from chickpea (full structure)
Treatment:
Dietary Supplement: chickpea
flour chickpea
Experimental group
Description:
a test meal containing 26g available carbohydrates from flour chickpea (destroyed structure)
Treatment:
Dietary Supplement: chickpea
intact cell chickpea
Experimental group
Description:
a test meal containing 26g available carbohydrates from intact cell chickpea flour (full structure)
Treatment:
Dietary Supplement: chickpea

Trial documents
2

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems